Brain Perfusion Scanners Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024
A brain perfusion scan is a type of brain test that provides information about brain function by demonstrating the amount of blood taken up by the brain cells and measure perfusion in the brain. Measuring perfusion is important for identification and treatment of stroke, other blood vessel diseases of the brain and brain tumors. Brain perfusion scan, require a radiotracer and nonradioactive substance for scanning of the brain. Factors such as, technological advancements in devices, increasing awareness about neurodegenerative diseases, the increasing incidence and prevalence of neurological disorders and growing incidence of brain injuries are driving the Brain perfusion scanners market. On the other hand, factors such as high cost of complex devices, shortage of trained professionals and concerns regarding the accuracy of diagnostic devices may hinder the growth of Brain perfusion scanners market. Some brain perfusion scan requires exposure you to radiation which increases the risk for cancer.
Brain Perfusion Scanners are used in different types of neurological indications such as Epilepsy, Dementia brain tumor, etc. According to WHO one billion peoples suffering from neurological disorders worldwide, 50 million suffer from epilepsy and 24 million from Alzheimer and 6.8 million people die every year as a result of neurological disorders. Brain perfusion takes only 60-75 second time to image the circulation in the brain. Some areas of the brain that are very active often show greater blood supply, so brain perfusion scanner also tracks these increase areas of the brain where blood supply is high and according to that a patient get treated.
The Global Brain perfusion scanners market is segmented by product type, Indication, End users and regional presence:
Segmentation based on product type
- Single Photon Emission Tomography (SPECT)
- Positron Emission Tomography (PET)
- Computed Tomography (CT)
- Magnetic resonance imaging (MRI).
Segmentation based on Indication
- Stroke or transient ischemic attack
- Subarachnoid hemorrhage
- Carotid stenosis
- Cerebral vasculitis
- Brain tumor
- Recent head injury
Segmentation based on End users
- Ambulatory Surgery Centers
- Diagnostic Labs and Imaging centers
Geographically the Brain perfusion scanners market is segmented into five key regions: North America, Latin America, Europe, APEJ, and MEA region. Magnetic resonance imaging (MRI) is highly used in brain diffusion scan followed by CT scan. MRI uses magnets and radio waves that show clearer images of brain tissue whereas CT scans used specialized kind of X-ray. Diffusion MRI measures molecular water motion in the tissue, showing where water diffusion is restricted and the cause of brain damage. According to American Academy of Neurology, the guidelines found in MRI scans are more accurately detect lesions from stroke and helped to identify the severity of stroke and other medical conditions.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15245
North America dominates the Brain perfusion scanners market due to, the presence of strong sales and distribution network, rising incidence of various neurological disorders, government initiatives, technological advancements in the field of neurosciences and availability of insurance coverage for brain monitoring techniques. According to American Academy of Neurology, Stroke is the third leading cause of death in the United States. 5.4 million Americans are currently diagnosed with Alzheimer’s disease and will triple to 16 million by the year 2050. North America is followed by Europe and Asia-Pacific. Asia Pacific region expected to be a third largest market globally due to technological innovation, increasing healthcare expenditure and increasing insurance coverage will fuel the overall brain perfusion scanners market.
Some major companies in the Brain perfusion scanners market are General Electric, Hitachi, Ltd., NeuroLogica Corp., Neusoft Corporation, Koninklijke Philips N.V., Siemens Healthineers, Toshiba Corporation, InfraScan, Inc., Medtronic Inc. among other significant players worldwide. Technological development is the key strategy among key players, for instance, Philips lunched Ingenia 3.0T MRI Scanner in 2015, first-ever digital broadband MR system.
Adhesive Bandages Market – Latest Innovations, Drivers, Restraints, Challenges and Forecast 2013 – 2019
Adhesive bandage, also known as sticking plaster, is a wound care dressing product that is utilized as small dressing. Adhesive bandages are applied on the patients who have not undergone serious accident but have minor abrasion (scratches) and cut on their body. The most widely utilized term for adhesive bandage by Americans is Band-Aid or Bandage; however, the British population terms them as plaster. Adhesive bandage help protect the cut or abrasion from bacteria, damage, friction and dirt and thus, results in quick healing process of the wound. It also helps hold the skin’s two cut ends together and hence fasten the healing process.
Adhesive bandage is covered with plastic, woven fabric or latex strip, which possesses the property of adhesion. A medicated absorbent pad with antiseptic solution is also present in an adhesive bandage. Some adhesive bandages contain thin and porous polymer coating on the medicated adsorbent pad that helps in sticking them to the wound. These adhesive bandages are applied in such as way that medicated adsorbent pad covers the wound (cut or abrasion), and the fabric of the bandage sticks to the nearby skin, to restrict the entry of germs and dirt into the wound.
Adhesive bandages can be segmented as: special bandages, transdermal patches and butterfly stitches. Special bandages are utilized by the people who are engaged in food prep work. They are blue colored waterproof bandages with strong adhesive property that resist their fall in food while manufacturing them. Transdermal patches are the adhesive bandages that help deliver medication through the skin and not protecting wound. Butterfly stitches are thin adhesive strips that are applied to close small wounds.
Increasing number of recreational activities by all age group of population will drive the growth of adhesive bandages market. Recreational activities like trekking results in multiple cuts and abrasion on the body that require the need for application of adhesive bandages, and in turn augment the demand for the same. Also, rising incidences of cuts in kitchen while cooking food will further accenture the growth of adhesive bandages market. Aging population will also boost the growth of adhesive bandages market since elderly people are usually met with small accidents such as stair fall and others. This generates the need for the application of bandages on the wounds, caused due to aforementioned accidents, hence support the growth of adhesive bandages market. Launch of different variants of adhesive bandages such as butterfly stitches will also trigger the growth of adhesive bandages market.
In 2012, North America accounted for the largest share of the global adhesive bandages market and is expected to grow at the highest CAGR during the forecast period. This growth is attributed to domicile of large number of adhesive bandage manufacturers in the region. Also, increasing number of small accidents in the region will augment the growth of adhesive bandages market. Also, adoption rate of various recreational activities for children by parents is high, that will help accentuate the growth of adhesive bandages market. Europe accounted for the second largest share of global adhesive bandages market owing to the presence of large geriatric population. Asia-pacific accounted for the third largest share of global adhesive bandages market followed by rest of the world. The major players operating in the adhesive bandages market include 3M, Johnson and Johnson, Smith & Nephew plc, Medline Industries, Inc., B. Braun Melsungen AG, Argentum Medical, Kinetic Concepts, Inc. and ConvaTec, Inc.
Transparency Market Research has published a new report on the global enteric disease testing market. According to the report, the global enteric disease testing market is expected to progress from US$3.1 bn in 2012 to US$3.6 bn by 2019. The report, titled ‘Enteric Disease Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,’ states that the global enteric disease testing market is expected to expand at a 2.40% CAGR during the period between 2013 and 2019 due to factors such as the increasing demand for rapid diagnosis, the untapped market in developing nations, and the increasing application of molecular diagnostics.
Enteric diseases or gastrointestinal infections are caused by a range of microbes comprising bacteria, parasites, and viruses, primarily when they enter the body via the mouth. Numerous microbes responsible for enteric diseases are salmonella, rotavirus, C. difficile, vibrio, campylobacter, shigella, and norovirus. These diseases may have mild or severe symptoms including bloody diarrhea, stool containing blood or pus, weight loss, fever, and abdominal cramps. To reduce the complications, enteric diseases have to be diagnosed early.
The global enteric disease testing market is segmented on the basis of geography and type of disease. Based on geography, the global enteric disease testing market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2012, in terms of growth and potential, Asia Pacific accounted for more than 50% of the global enteric disease testing market. Factors such as the rising awareness, high occurrence of enteric diseases, and the inception of quick diagnostic tests are expected to propel the Asia Pacific enteric disease testing market in the next few years. The high level of consumer awareness is expected to propel the North America enteric disease testing market in the years to come. Some of the leading players in the global enteric disease testing market are DiaSorin, Alere, Meridian Bioscience, Cepheid, and Biomerica.
By type of disease, the global enteric disease testing market is classified into bacterial enteric disease testing, viral enteric disease testing, and parasitic enteric disease testing. The bacterial enteric disease testing segment is sub-segmented into C. difficile infection, cholera, E. coli infection, campylobacteriosis, and others. Earlier, the diagnosis of enteric diseases depended on culture results of stool samples. However, today, the trend is shifting towards other diagnostic methods due to the many limitations connected with culture tests. High cost and the requirement for sophisticated laboratory equipment, labor, and skilled personnel are some of the drawbacks related to culture tests. In many developed regions, PCR-based diagnostic procedures are recommended to test enteric diseases as they offer high specificity and sensitivity and are rapid, accurate, and easy to manage.
Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258
The global enteric disease testing market is expected to be hampered by factors such as the growing occurrence of mild and asymptomatic diseases and lack of awareness. However, the global enteric disease testing market is expected to register considerable growth due to the rising opportunities in molecular-diagnostics-based enteric disease testing and the growing opportunities in developing nations.
In a report, titled “Hematology Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” Transparency Market Research presents a comprehensive overview of the factors impacting the growth trajectory of the global market for hematology diagnostics between 2015 and 2023.
Hematology is a branch of medicine dealing with the diagnosis, treatment, and prevention of ailments related to the bone marrow, blood, immunology, the vascular system, and hemostasis (blood clotting). Hematological tests are carried out to diagnose various blood-related diseases such as anemia, leukemia, blood cancer, and autoimmune disorders, among others. The method encompasses various in vitro diagnostic (IVD) techniques such as hemostasis, molecular diagnostics, blood analysis, flow cytometry, and immunodiagnostics, which help in measuring various parameters of blood with improved precision at a comparatively lower cost.
The increasing incidence of blood-related disorders has been a key factor driving the global market for hematology diagnostics. As per data released by the Leukemia & Lymphoma Society (LLS), in the U.S. alone, approximately 1.6 million new cases of cancer were reported in 2015. About 9.8% of this demographic were diagnosed with leukemia, lymphoma, and myeloma. Additionally, as per the findings of the National Hemophilia Foundation, approximately 400,000 cases of people suffering from hemophilia are registered globally. With the population of people aged above 65 years being projected to reach over 83.7 million by 2050, as per the Administration for Community Living, which is twice that estimated in 2012, the market for hematology diagnostics is anticipated to exponentially grow in the near future.
Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8848
It is therefore extremely important for vendors operating in the market for hematology diagnostics to be well aware of the market’s present dynamics and how various factors will shape its future. The information comprised in the report is aimed at assisting the market stakeholders with insights pertaining to the prevailing trends and projected factors that may influence the market’s growth trajectory over the forecast period.
Providing in-depth information pertaining to the technological developments and government policies supporting the further development of healthcare infrastructure across the most lucrative regions, the report makes for a resourceful guidebook for those seeking pertinent information about the hematology diagnostics market.
The report broadly classifies the global hematology diagnostics market on the basis of end user, product, and geography. By product, the market is bifurcated into hematology reagents and hematology analyzers. Based on end user, the market is segmented into clinical laboratories, hospitals, research institutes, and academics institutes.
Regionally, the global hematology diagnostics market constitutes Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Of these, North America presently dominates the global hematology diagnostics market. However, the market in Asia Pacific is expected to exhibit the highest CAGR during the forecast period.
To provide a holistic overview of the prevailing competitive scenario of the market for hematology diagnostics, the report profiles some of the most prominent vendors operating in the market, such as HemoCue AB, Beckman Coulter, Sysmex, Abbott Laboratories, Mindray Medical HORIBA, Ltd., International Limited., Roche Diagnostics A/S, Siemens AG, and Bio-Rad Laboratories, Inc.
Transparency Market Research has published a new report on the global teleradiology market. As per the report, the global teleradiology market is predicted to expand at a 22.30% CAGR during the period between 2013 and 2019. The report, titled ‘Teleradiology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019,’ states that the global teleradiology market stood at US$0.9 bn in 2012 and is expected to reach US$3.8 bn by 2019 owing to factors such as technological advancements and the introduction of mhealth services.
Teleradiology consists of the electronic transmission of radiological images from a particular location to another in a digital format using the internet. Image transfer is primarily carried out from the sender’s end to a secondary location for either consultation or an official diagnosis. Consistent developments and advancements in digital imaging technology have favored the acceptance of teleradiology technologies. The increasing acceptance of social media platforms and the internet in general is further expected to augment the use of teleradiology practices across the globe.
Continuous upgradation of radiology information systems (RIS) and picture archiving and communication systems (PACS) is expected to enhance the teleradiology process. The global teleradiology market is segmented on the basis of geography and modality. Based on modality, the global teleradiology market is classified into x-ray, ultrasound, computed tomography (CT), nuclear imaging, and magnetic resonance imaging (MRI). The x-ray teleradiology segment is expected to register new growth opportunities due to increased awareness, low costs compared to other modalities, and increasing digitalization.
Ultrasound imaging technology, popularly used in diagnosing women’s ailments, is majorly employed to track and visualize development stages of a fetus at the time of pregnancy. Compared with x-rays, ultrasound imaging technology is more beneficial due to its minimally invasive nature. The acceptance of MRI imaging technology is still at a nascent stage due to the high costs of the equipment and lack of technical expertise.
Based on geography, the global teleradiology market is divided into Europe, Asia Pacific, North America, and Rest of the World. In 2012, the global teleradiology market was led by North America, which held a revenue share of more than 33%. The presence of well-equipped healthcare institutions and hospitals and the increasing use of high-bandwidth internet are predicted to propel the North America teleradiology market in the years to come.
The Asia Pacific teleradiology market is expected to register considerable growth in the coming few years due to ongoing developments in healthcare informatics and medical imaging platforms. However, lack of image data security is expected to hamper the growth of the global teleradiology market through the forecast period.
Agfa-Gevaert N.V., American TeleCare, Inc., Cybernet Systems Corporation, ONRAD, Inc., Radisphere National Radiology Group, Inc., Sectra AB, StatRad, Teleradiology Solutions, and Virtual Radiologic (vRad) are some of the leading companies in the global teleradiology market. The entry of new companies is expected to make the global teleradiology market highly competitive in the coming years.